Details for New Drug Application (NDA): 050761
✉ Email this page to a colleague
NDA 050761 describes AMOXIL, which is a drug marketed by Glaxosmithkline and Us Antibiotics and is included in eight NDAs. It is available from three suppliers. Additional details are available on the AMOXIL profile page.
The generic ingredient in AMOXIL is amoxicillin. There are forty-six drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the amoxicillin profile page.
The generic ingredient in AMOXIL is amoxicillin. There are forty-six drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the amoxicillin profile page.
Summary for 050761
| Tradename: | AMOXIL |
| Applicant: | Us Antibiotics |
| Ingredient: | amoxicillin |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050761
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, CHEWABLE;ORAL | Strength | 200MG | ||||
| Approval Date: | Apr 15, 1999 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, CHEWABLE;ORAL | Strength | 400MG | ||||
| Approval Date: | Apr 15, 1999 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
